Dextran sulfate sodium colitis study Wild-type mice (812 weeks of age) were allowed ad libitum access to drinking water containing 1.5%2% dextran sulfate sodium (DSS, MW = 36,00050,000
Recommendations in this article are extrapolated from non-pharmacologic weight-loss literature, body-composition substudies of GLP-1 trials, and 2024-2025 case reports.
As obesity rates soar, so does the prevalence of: Type 2 diabetes: Linked to 80-85% of T2D cases, a disease costing the U.S
This case describes a patient who underwent a structured, minimally invasive treatment approach to restore facial aesthetics following semaglutide-induced weight loss
Breiman, L
Methods: The effect of either hydrophilic intestine restricted fernesiod X receptor (FXR) antagonist Glycine-beta-Muricholic acid (Gly-b-MCA) or hydrophilic Ursodeoxycholic acid (UDCA) treatment at a dose of 160mg/kg/day for 4 weeks on bile acid pool and composition, hepatic inflammation, ductular reaction, and portal fibrosis were investigated in Cyp2c70 KO mice